- Home
- TLX vs LPX Comparison
TLX vs LPX Comparison
Compare TLX & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- LPX
- Stock Information
- Founded
- TLX 2015
- LPX 1973
- Country
- TLX Australia
- LPX United States
- Employees
- TLX N/A
- LPX N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- LPX Forest Products
- Sector
- TLX Health Care
- LPX Basic Materials
- Exchange
- TLX Nasdaq
- LPX Nasdaq
- Market Cap
- TLX 6.0B
- LPX 6.2B
- IPO Year
- TLX N/A
- LPX N/A
- Fundamental
- Price
- TLX $16.71
- LPX $84.20
- Analyst Decision
- TLX Strong Buy
- LPX Hold
- Analyst Count
- TLX 1
- LPX 9
- Target Price
- TLX $22.00
- LPX $112.25
- AVG Volume (30 Days)
- TLX 28.3K
- LPX 644.8K
- Earning Date
- TLX 01-01-0001
- LPX 05-06-2025
- Dividend Yield
- TLX N/A
- LPX 1.33%
- EPS Growth
- TLX 798.14
- LPX 139.43
- EPS
- TLX 0.09
- LPX 5.89
- Revenue
- TLX $484,687,790.00
- LPX $2,941,000,000.00
- Revenue This Year
- TLX N/A
- LPX $3.37
- Revenue Next Year
- TLX N/A
- LPX $7.01
- P/E Ratio
- TLX $179.17
- LPX $14.30
- Revenue Growth
- TLX 55.85
- LPX 13.95
- 52 Week Low
- TLX $13.61
- LPX $71.39
- 52 Week High
- TLX $30.36
- LPX $122.87
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- LPX 38.84
- Support Level
- TLX N/A
- LPX $82.67
- Resistance Level
- TLX N/A
- LPX $87.92
- Average True Range (ATR)
- TLX 0.00
- LPX 4.37
- MACD
- TLX 0.00
- LPX 0.03
- Stochastic Oscillator
- TLX 0.00
- LPX 35.58
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About LPX Louisiana-Pacific Corporation
Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.